These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Utility of recombinant human thyrotropin for augmentation of radioiodine uptake and treatment of nontoxic and toxic multinodular goiters. Duick DS; Baskin HJ Endocr Pract; 2003; 9(3):204-9. PubMed ID: 12917062 [TBL] [Abstract][Full Text] [Related]
24. Modified-release recombinant human TSH (MRrhTSH) augments the effect of (131)I therapy in benign multinodular goiter: results from a multicenter international, randomized, placebo-controlled study. Graf H; Fast S; Pacini F; Pinchera A; Leung A; Vaisman M; Reiners C; Wemeau JL; Huysmans D; Harper W; Driedger A; de Souza HN; Castagna MG; Antonangeli L; Braverman L; Corbo R; Düren C; Proust-Lemoine E; Edelbroek MA; Marriott C; Rachinsky I; Grupe P; Watt T; Magner J; Hegedus L J Clin Endocrinol Metab; 2011 May; 96(5):1368-76. PubMed ID: 21346067 [TBL] [Abstract][Full Text] [Related]
25. An outline concerning the potential use of recombinant human thyrotropin for improving radioiodine therapy of multinodular goiter. Medeiros-Neto G; Marui S; Knobel M Endocrine; 2008 Apr; 33(2):109-17. PubMed ID: 18491237 [TBL] [Abstract][Full Text] [Related]
26. Diffuse nontoxic and multinodular goiter. Nakhjavani M; Gharib H Curr Ther Endocrinol Metab; 1997; 6():109-12. PubMed ID: 9174716 [No Abstract] [Full Text] [Related]
27. Long-term outcome after radioiodine therapy with adjuvant rhTSH treatment: comparison between patients with non-toxic and pre-toxic large multinodular goitre. Giusti M; Caorsi V; Mortara L; Caputo M; Monti E; Schiavo M; Bagnara MC; Minuto F; Bagnasco M Endocrine; 2014 Mar; 45(2):221-9. PubMed ID: 23619962 [TBL] [Abstract][Full Text] [Related]
28. Recombinant human thyrotropin as adjuvant in the treatment of multinodular goiters with radioiodine. Albino CC; Mesa CO; Olandoski M; Ueda CE; Woellner LC; Goedert CA; Souza AM; Graf H J Clin Endocrinol Metab; 2005 May; 90(5):2775-80. PubMed ID: 15713700 [TBL] [Abstract][Full Text] [Related]
29. Prestimulation with recombinant human thyrotropin (rhTSH) improves the long-term outcome of radioiodine therapy for multinodular nontoxic goiter. Fast S; Nielsen VE; Grupe P; Boel-Jørgensen H; Bastholt L; Andersen PB; Bonnema SJ; Hegedüs L J Clin Endocrinol Metab; 2012 Aug; 97(8):2653-60. PubMed ID: 22577172 [TBL] [Abstract][Full Text] [Related]
30. How the availability of recombinant human TSH has changed the management of patients who have thyroid cancer. Schlumberger M; Ricard M; De Pouvourville G; Pacini F Nat Clin Pract Endocrinol Metab; 2007 Sep; 3(9):641-50. PubMed ID: 17710085 [TBL] [Abstract][Full Text] [Related]
31. Establishing and Monitoring an Effective Management of Benign Nontoxic Multinodular Goitre in Kuwait "Utilizing Two Different Dose Levels of Recombinant Human TSH in Combination with Radioactive Iodine". Al-Shammeri I; Masoomi M; Al-Shammeri N; Al-Abdali F; Al-Shagooli A Gulf J Oncolog; 2024 May; 1(45):49-63. PubMed ID: 38774933 [TBL] [Abstract][Full Text] [Related]